Keyword: SOS Ventures

Prellis Biologics has assembled $8.7 million in new funding alongside positive news from the first transplantation of its vascular tissue scaffolds.

DNAlite Therapeutics gathered $1.5 million in seed money for gene therapies that slip through the mucus typically blocking access to the GI tract.